ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,596.73
0.17%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Takeda Pharmaceutical Co Ltd (PK) (TKPHF)

  7. Takeda Pharmaceutical Co Ltd (PK) (TKPHF) News

Takeda Pharmaceutical (PK) (TKPHF)

Takeda Pharmaceutical Co Ltd (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:TKPHF
DateTimeSourceHeadlineSymbolCompany
29/05/202411:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
29/05/202411:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
29/05/202411:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
29/05/202411:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
09/05/202411:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
09/05/202411:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
09/05/202411:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
09/05/202411:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
09/05/202411:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
09/02/202411:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
05/02/202411:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
02/02/202411:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
30/11/202311:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
13/11/202311:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
26/10/202311:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
26/10/202311:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
02/10/202311:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
28/09/202311:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
12/07/202311:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
10/07/202311:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:TKPHFTakeda Pharmaceutical Co Ltd (PK)
 Showing the most relevant articles for your search:USOTC:TKPHF

Your Recent History

NYSE
ACRO
Acropolis Infrastructure...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved